Evidence brief · printable

Post-Acute COVID/Vaccination Syndrome evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Post-Acute COVID/Vaccination Syndrome

Print or save as PDF Fits on one A4 or Letter page.

Post-Acute COVID/Vaccination Syndrome: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/post-acute-covidvaccination-syndrome.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Immunoadsorption 2 trials
  • 6-minute walk 1 trial
  • Active 1 trial
  • Computed Tomography of the Chest 1 trial
  • COVAXIN 1 trial
  • DAOIB (see NCT05764538) 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Herbal medicines and traditional formulas 1 trials · 1 completed · 0 with results
  • Exercise programmes (mixed or unspecified) 2 trials · 1 completed · 0 with results

Biomarkers reported

Direction in patients compared with the stated comparison group, as reported in the cited study.

  • S1 in CD16+ monocytes higher · Patterson et al. 2025
  • Circulating spike (post-mRNA myocarditis) higher · Yonker et al. 2023
  • Spike in cutaneous lesions higher · Sano et al. 2025
  • Spike in neurological tissue higher · Ota et al. 2025
  • Anti-Spike (Anti-S) antibodies higher · Federico 2024
  • Anti-Nucleocapsid (Anti-N) antibodies lower · Federico 2024

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long… NCT06960928
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (3 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page · biomarker atlas. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.